Current status: 827 hESC lines, 3093 hiPSC lines, and 96 clinical studies, and 403 certificates
Monthly statistic from Apr 1, 2022
Posted on April 1, 2022
| total lines | 3920 |
| hESC lines | 827 |
| hiPSC lines | 3093 |
| derivation countries | 43 |
| projects | 223 |
| providers | 707 |
| clinical studies | 96 |
| subclones | 1498 |
| certificates | 403 |
| cell line certificates | 293 |
| project certificates | 110 |